| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/12/2002 | CA2187214C Aminostilbazole derivative and medicine |
| 03/12/2002 | CA2060393C Carbamic acid derivatives and method for preparing the same |
| 03/12/2002 | CA2055947C Condensed heterocyclic compounds, their production and use |
| 03/12/2002 | CA2053527C Pyridine derivatives, their production and use |
| 03/07/2002 | WO2002018540A2 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | WO2002018384A1 Process for the preparation of vitronectin receptor antagonists |
| 03/07/2002 | WO2002018377A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/07/2002 | WO2002018368A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | WO2002018367A1 Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable |
| 03/07/2002 | WO2002018366A1 Process for the synthesis of n-(5-methylnicotinoyl)-4-hydroxypiperidine, a key intermediate of rupatadine |
| 03/07/2002 | WO2002018348A2 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002018344A1 Novel ester or amide derivatives |
| 03/07/2002 | WO2002018340A1 GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
| 03/07/2002 | WO2002018339A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002017924A1 Method of treatment |
| 03/07/2002 | WO2002017916A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/07/2002 | WO2001090103A9 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists |
| 03/07/2002 | WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels |
| 03/07/2002 | WO2001064226A3 Farnesyl protein transferase inhibitor combinations with platinum compounds |
| 03/07/2002 | WO2001062765A3 Small molecule modulators of g protein-coupled receptor six |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028933 Thioamide derivatives |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 03/07/2002 | US20020028834 Heterocyclic-cyclic amine derivatives |
| 03/07/2002 | US20020028832 Substituted 4-((4-amino-5-hydroxyphenyl)-oxy-)piperidine analogs; metabolic disorders; antidiabetic agents; athero-sclerosis, gastrointestinal disorders, glaucoma, neurogenetic inflammation, ocular hypertension and frequent urination |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | US20020028819 Piperazinedione compounds |
| 03/07/2002 | US20020028814 Aza compounds, pharmaceutical compositions and methods of use |
| 03/07/2002 | US20020028812 Phenylalanine derivatives |
| 03/07/2002 | US20020028810 Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
| 03/07/2002 | US20020028797 Therapy for metabolism diseases; dietetics; antidiabetic agents |
| 03/07/2002 | US20020028760 Nervous system disorders; hypotensive agents; incontinence |
| 03/07/2002 | DE10035928A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments |
| 03/07/2002 | CA2420673A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2419841A1 Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
| 03/07/2002 | CA2419616A1 Novel ester or amide derivatives |
| 03/07/2002 | CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/06/2002 | EP1184374A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 03/06/2002 | EP1184373A1 Tricyclic compounds |
| 03/06/2002 | EP1183254A1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 03/06/2002 | EP1183252A1 New pharmaceutically active compounds |
| 03/06/2002 | EP1183251A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | EP1183243A1 Short-acting benzodiazepines |
| 03/06/2002 | EP1183242A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183238A1 Metabotropic glutamate receptor antagonists |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP0994865B1 Triazole compounds and the use thereof as dopamine-d 3-ligands |
| 03/06/2002 | EP0991640B1 Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds |
| 03/06/2002 | EP0946548B1 Novel heterocyclic substituted pyrrolidine amide derivatives |
| 03/06/2002 | EP0907648B1 Quinolone carboxylic acids substituted by 7-(3-vinyl-1,4-piperazine-1-yl) |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/06/2002 | EP0819122B1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 03/06/2002 | EP0740657B1 4-arylisoindole analgesics |
| 03/06/2002 | EP0695295B1 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation |
| 03/06/2002 | CN1339034A Potassium salt of (I(S))-omeprazole |
| 03/06/2002 | CN1339025A Indole derivatives and their use as MCP-1 antagonists |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338454A Cyclic amino acid and cyclohydroxycarboxylic derivative substituted benzamidine derivatives and their uses as anticoagulants |
| 03/06/2002 | CN1080283C Synergic stabilizato mixture |
| 03/06/2002 | CN1080262C Novel substituted 4-(1H-benzimidazol-2-YL)[1,4] diazepanes useful for the treatment of allergic diseases |
| 03/06/2002 | CN1080261C 3-substituted 1-arylindole compounds |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/06/2002 | CN1080125C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
| 03/05/2002 | US6353109 Psychological disorders; sleep disorders; anticonvulsants; cognition activators |
| 03/05/2002 | US6353108 1-(3-pyridinyl)-ethanone o-((4-methylphenyl) sulphonyl) oxime forms 3-(2h-azirin-3-yl)-pyridine which is reacted with acid and alcohol to obtain the 2,2-dimethoxy-2-(3-pyridinyl) ethyl-amine which is reacted with an amide and cyclized; intermediates are not isolated |
| 03/05/2002 | US6353107 1-alkoxy-polyallkyl-piperidine derivatives and their use as polymerization regulators |
| 03/05/2002 | US6353103 Stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety. |
| 03/05/2002 | US6353044 Light-stabilized organic polymers |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6353007 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6353001 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
| 03/05/2002 | US6352994 Nervous system disorders; psychological disorders |
| 03/05/2002 | US6352993 Pyrimidine derivatives and processes for the preparation thereof |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352988 High affinity for d4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 03/05/2002 | US6352985 Benzimidazole compounds |
| 03/05/2002 | US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses |
| 03/05/2002 | US6352566 Ethers of polyalkyl or polyalkenyl N-hydroxyalkyl succinimides and fuel compositions containing the same |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 03/05/2002 | CA2266565C Azabicyclic rotomase inhibitors |
| 03/05/2002 | CA2215013C N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 02/28/2002 | WO2002016362A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016361A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016360A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016353A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders |
| 02/28/2002 | WO2002016351A1 Quinazoline derivatives as kinase inhibitors |